| Adenine-induced chronic kidney disease in rats |
22 |
| Glomerular mesangial cell and podocyte injuries in diabetic nephropathy |
22 |
| New insights into the role and mechanism of Wnt/-catenin signalling in kidney fibrosis |
19 |
| Cost-utility analysis of the National Health Screening Program for chronic kidney disease in Korea |
17 |
| Diet, gut microbiome and indoxyl sulphate in chronic kidney disease patients |
13 |
| Chronic kidney disease epidemic: How do we deal with it? |
12 |
| Mechanism of valproic acid-induced Fanconi syndrome involves mitochondrial dysfunction and oxidative stress in rat kidney |
12 |
| Systematic review of sodium thiosulfate in treating calciphylaxis in chronic kidney disease patients |
12 |
| Mineral bone disorders in chronic kidney disease |
11 |
| Gastrointestinal symptoms in patients receiving dialysis: A systematic review |
11 |
| Effects of the sodium-glucose cotransporter 2 inhibitor dapagliflozin on fluid distribution: A comparison study with furosemide and tolvaptan |
10 |
| Effect of long non-coding RNA growth arrest-specific 5 on apoptosis in renal ischaemia/reperfusion injury |
9 |
| Taiwan renal care system: A learning health-care system |
9 |
| Acute Kidney Injury and mortality prognosis in Acute Coronary Syndrome patients: A meta-analysis |
9 |
| Mesenchymal stem cells attenuate adriamycin-induced nephropathy by diminishing oxidative stress and inflammation via downregulation of the NF-kB |
8 |
| Renoprotective effects of topiroxostat for Hyperuricaemic patients with overt diabetic nephropathy study (ETUDE study): A prospective, randomized, multicentre clinical trial |
8 |
| Validation of acute kidney injury according to the modified KDIGO criteria in infants after cardiac surgery for congenital heart disease |
8 |
| Nephronophthisis: A review of genotype-phenotype correlation |
8 |
| Desmopressin (Octostim (R)) before a native kidney biopsy can reduce the risk for biopsy complications in patients with impaired renal function: A pilot study |
7 |
| LncRNA HOTAIR promotes renal interstitial fibrosis by regulating Notch1 pathway via the modulation of miR-124 |
7 |
| Lupus nephritis: An update on treatments and pathogenesis |
7 |
| Systemic immune-inflammation index could estimate the cross-sectional high activity and the poor outcomes in immunosuppressive drug-naive patients with antineutrophil cytoplasmic antibody-associated vasculitis |
7 |
| Periodontal and chronic kidney disease association: A systematic review and meta-analysis |
7 |
| Loss of appendicular muscle mass in haemodialysis patients is associated with increased self-reported depression, anxiety and lower general health scores |
7 |
| Salt, water and nephron: Mechanisms of action and link to hypertension and chronic kidney disease |
7 |
| Spectrum of chronic kidney disease in China: A national study based on hospitalized patients from 2010 to 2015 |
7 |
| Human umbilical cord-derived mesenchymal stem cells conditioned medium attenuate interstitial fibrosis and stimulate the repair of tubular epithelial cells in an irreversible model of unilateral ureteral obstruction |
7 |
| F Gathering Perspectives - Finding Solutions for Chronic and End Stage Kidney Disease |
7 |
| Big data in nephrology: Are we ready for the change? |
7 |
| Identifying patient-important outcomes in polycystic kidney disease: An international nominal group technique study |
6 |
| Prevalence and associated variables of post-dialysis fatigue: Results of a prospective multicentre study |
6 |
| Age-specific risk of renal graft loss from late acute rejection or non-compliance in the adolescent and young adult period |
6 |
| Role of renin-angiotensin system in acute kidney injury-chronic kidney disease transition |
6 |
| Biomarkers for acute kidney injury in decompensated cirrhosis: A prospective study |
6 |
| Is immunoglobulin A nephropathy different in different ethnic populations? |
6 |
| Lithium and nephrotoxicity: Unravelling the complex pathophysiological threads of the lightest metal |
6 |
| iConnect CKD - virtual medical consulting: A web-based chronic kidney disease, hypertension and diabetes integrated care program |
6 |
| Warfarin use and the risk of stroke, bleeding, and mortality in older adults on dialysis with incident atrial fibrillation |
5 |
| Sofosbuvir-based treatment is safe and effective in Indian hepatitis C patients on maintenance haemodialysis: A retrospective study |
5 |
| Biomarkers for acute cardiorenal syndrome |
5 |
| Kinetic estimated glomerular filtration rate as a predictor of successful continuous renal replacement therapy discontinuation |
5 |
| Prospective associations between environmental heavy metal exposure and renal outcomes in adults with chronic kidney disease |
5 |
| Observation period for changes in proteinuria and risk prediction of end-stage renal disease in general population |
5 |
| Heart rate variability as a predictor of rapid renal function deterioration in chronic kidney disease patients |
5 |
| Complement in glomerular diseases |
5 |
| Models of care for chronic kidney disease: A systematic review |
5 |
| Role of Kruppel-like factor-2 in kidney disease |
5 |
| Serum procalcitonin levels predict acute kidney injury in critically ill patients |
5 |
| Management considerations in the failing renal allograft |
5 |
| Compensatory renal hypertrophy following nephrectomy: When and how? |
5 |
